Sir,

Valproic acid (VA) is a frequently used drug with an increase in fatal overdoses \[[@R1]\]. Coma, respiratory failure, cerebral oedema, pancreatitis and impairment of mitochondrial β oxidation can be seen in severe poisoning \[[@R2]\]. Treatment mainly consists of supportive care. Extracorporeal elimination of VA can be considered. The use of haemoperfusion and haemodialysis (HD) have been reported, but with conflicting results. We report a case of severe VA overdose, where continuous venovenous haemodiafiltration (CVVHDF) led to a significant decrease in blood levels. A 54-year-old woman was admitted to our intensive care unit after a VA overdose. She was unconscious and required mechanical ventilation. Blood VA level on admission was 1664 μg/mL. The patient\'s condition progressively worsened. The day after admission, she demonstrated most of the VA poisoning symptoms. Despite supportive care, her status deteriorated, leading to multiple organ failure. CVVHDF was initiated for acute renal failure and anuria with an AN69 hollow-fibre dialyzer of 0.9 m^2^ (Hospal, Lyon, France), using the predilutional method, with blood flow set at 120 mL/min. The dialysate and substitution fluid rates were 1000 mL/min and 2000 mL/min, respectively (Hemosol, Hospal, Lyon, France). Arterial blood samples were collected from the sampling point of the dialyzer, which is at a point before the blood passes through the haemofilter. Paired ultradiafiltrate samples were collected. VA concentration was measured by a fluorescence polarization immunoassay. VA clearance was determined as Cl = \[*C*~UF~ \* *V*~UF~\]/\[*C*~A~ \* *t*\] where *C*~UF~ and *C*~A~ are ultradiafitrate and arterial serum VA concentrations at the midpoint of the time of collection, respectively; *V*~UF~ is ultradiafiltrate volume and *t* is the time of collection. The sieving coefficient (Sc) was calculated as Sc = *C*~UF~/*C*~A~ ([Table 1](#T1){ref-type="table"}).

###### 

Valproic acid blood and ultradiafiltrate concentrations, clearance, and sieving coefficient.

                                       ICU admission Hours after start of CVVHDF               
  ------------------------------------ ------------------------------------------- ----- ----- -----
  Valproic acid concentration, μg/mL                                                           
  Blood                                1664                                        943   758   417
  Ultradiafiltrate                                                                       335   303
  Valproic acid clearance, mL/min      11                                                      
  Sieving coefficient                  0.44                                                    

VA is a small (144 Da), water-soluble molecule with a volume of distribution ranging from 0.1 to 0.5 L/kg. At therapeutic levels, VA is almost completely bound to plasma proteins; thus drug removal by extrarenal epuration is negligible. In the case of overdose, a much larger percentage of VA is unbound and so accessible to extrarenal epuration techniques \[[@R3]\]. Johnson \[[@R4]\] reported that the use of HD with a high dialysate flow rate (800 mL/min) is effective in obtaining excellent clearance of the drug (\>80 mL/min). Hicks \[[@R5]\] found a marked decrease in serum VA occurring after 7.7 h of HD, and an improvement of VA half-life from 31.3 to 2.25 h. HD can be difficult to perform (particularly with high blood or dialysate flow rates) in patients with haemodynamic instability. In such a case, continuous renal replacement therapies may be an alternative, but very few data are available on their efficacy. Our results suggest that CVVHDF, although less effective than HD, significantly lowers VA blood concentration in the case of overdose. Indeed, no definitive conclusion about the clinical usefulness of this technique can be drawn from these data.
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